Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
J Colloid Interface Sci ; 646: 426-437, 2023 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-37207424

RESUMEN

Texture and mouthfeel are central to the sensory enjoyment of food and beverages. Yet our incomplete understanding of how food boluses are transformed in the mouth limits our texture prediction ability. As well as thin film tribology, the interaction of food colloids with the oral tissue and salivary biofilms plays a key role in texture perception via mechanoreceptors in the papillae. In this study we describe the development of an oral microscope capable of quantitative characterization of the inactions of food colloids with papillae and their concurrent saliva biofilm. We also highlight how the oral microscope revealed key microstructural drivers of several topical phenomena (oral residue formation, coalescence in-mouth, grittiness of protein aggregates and finally microstructural origin of polyphenol astringency) in the domain of texture creation. The coupling of a fluorescent food grade dye with image analysis enabled specific and quantitative determination of the microstructural changes in mouth. Emulsions either underwent no aggregation, small aggregation, or extensive aggregation depending on whether their surface charge facilitated complexation with the saliva biofilm. Quite surprisingly cationic gelatin emulsions that were already aggregated with saliva in mouth underwent coalescence if subsequently exposed to tea polyphenols (EGCG). Large protein aggregates were found to aggregate with the saliva coated papillae, increasing their size tenfold and possibly explaining why there are perceived as gritty. An exciting observation was the oral microstructural changes that occurred upon exposure to tea polyphenols (EGCG). Filiform papillae shrunk, and the saliva biofilm was seen to precipitate/collapse, exposing a very rough tissue surface. These tentative early steps are the first in vivo microstructural insights into the different food oral transformations that are drivers of key texture sensation.


Asunto(s)
Boca , Agregado de Proteínas , Fricción , Boca/metabolismo , Saliva/química , Emulsiones/metabolismo , Coloides/metabolismo , Polifenoles , , Biopelículas
2.
Pharm Dev Technol ; 26(6): 682-692, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33952085

RESUMEN

Although there are several treatments for rheumatoid arthritis (RA), outcomes are unsatisfactory and often associated with many side effects. We attempted to improve RA therapeutic outcomes by intra-articular administration of dual drug-loaded poly(lactic) acid (PLA)-coated herbal colloidal carriers (HCCs). Curcumin (CU) and resveratrol (RES) were loaded into HCCs because of their safety and significant anti-inflammatory activity. HCCs were prepared using a high-pressure, hot homogenization technique and evaluated in vitro and in vivo using a complete Freund's adjuvant-induced arthritis model. Transmission electron microscope (TEM) evaluated coating selected formulations with PLA, which increased particle sizes from 52 to 89.14 nm. The entrapment efficiency of both formulations was approximately 76%. HCCs significantly increased the amount of RES and CU released compared with the drug suspensions alone. The in vivo treated groups showed a significant improvement in joint healing. PLA-coated HCCs, followed by uncoated HCCs, yielded the highest reductions in knee diameter, myeloperoxidase (MPO) levels, and tumor necrosis factor-alpha (TNFα) levels. Histological examination of the dissected joints revealed that PLA-coated HCCs followed by uncoated HCCs exhibited the most significant joint healing effects. Our results demonstrate the superiority of intra-articularly administered HCCs to suppress RA progression compared with RES or CU suspensions alone.


Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Coloides/administración & dosificación , Portadores de Fármacos/administración & dosificación , Preparaciones de Plantas/administración & dosificación , Poliésteres/administración & dosificación , Animales , Artritis Reumatoide/inducido químicamente , Artritis Reumatoide/metabolismo , Coloides/metabolismo , Portadores de Fármacos/metabolismo , Adyuvante de Freund/toxicidad , Inyecciones Intraarticulares/métodos , Masculino , Preparaciones de Plantas/metabolismo , Poliésteres/metabolismo , Ratas
3.
Int J Mol Sci ; 21(10)2020 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-32455881

RESUMEN

Several proteins from animal and plant origin act as microbial transglutaminase substrate, a crosslinking enzyme capable of introducing isopeptide bonds into proteins between the aminoacids glutamines and lysines. This feature has been widely exploited to modify the biological properties of many proteins, such as emulsifying, gelling, viscosity, and foaming. Besides, microbial transglutaminase has been used to prepare bioplastics that, because made of renewable molecules, are able to replace the high polluting plastics of petrochemical origin. In fact, most of the time, it has been shown that the microbial enzyme strengthens the matrix of protein-based bioplastics, thus, influencing the technological characteristics of the derived materials. In this review, an overview of the ability of many proteins to behave as good substrates of the enzyme and their ability to give rise to bioplastics with improved properties is presented. Different applications of this enzyme confirm its important role as an additive to recover high value-added protein containing by-products with a double aim (i) to produce environmentally friendly materials and (ii) to find alternative uses of wastes as renewable, cheap, and non-polluting sources. Both principles are in line with the bio-economy paradigm.


Asunto(s)
Coloides/química , Proteínas de Plantas/química , Plásticos/química , Transglutaminasas/metabolismo , Animales , Biodegradación Ambiental , Biotecnología , Colágeno/química , Colágeno/metabolismo , Coloides/metabolismo , Proteínas del Huevo/química , Proteínas del Huevo/metabolismo , Contaminación Ambiental , Glutamina/química , Lisina/química , Proteínas de la Leche/química , Proteínas de la Leche/metabolismo , Pectinas/química , Pectinas/metabolismo
4.
Chemosphere ; 236: 124341, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31545183

RESUMEN

Knowledge on the bioavailability of trace elements is essential in developing environmental quality standards. The purpose of this study was to explore the relationships between trace elements (in particular Uranium (U)) in sediments, porewater and their bioaccumulation by Chironomus riparius on a uranium mining site and river sediments upstream of the mine. The mobility and speciation of U in sediments was investigated using DGT. Geochemical modelling using CHESS provided insight on sorption behavior of U on ironoxyhydrite (HFO) and aqueous speciation of U. In the upstream site U concentrations found were 0.05 µmol g-1 in surface sediment, 0.84 nmol L-1 in porewater and 2.4 nmol g-1 in Chironomus riparius whereas in the ferrihydrite deposits on the mining sites the concentrations found were up to 9.4 µmol g-1 in surface sediment, 0.37 µmol L-1 in porewater and 0.684 µmol g-1 in in Chironomus riparius. Despite the large differences in concentrations of U between the two sites, sediment to dissolved partitioning coefficients, bioconcentration factor (BCF) and biota sediment accumulation factors (BSAF) were very comparable. In the upstream sediment binding of U to organic matter controls sorption and aqueous speciation of U, whereas in the HFO rich sediments, sorption on HFO and the formation of HFO colloids are the determining factors. The low BSAF factors and high BCF factors indicate that the bioaccumulation is due to uptake from the dissolved phase. The DGT probes with different binding resins provide information on the colloidal nature and lability of the dissolved U species.


Asunto(s)
Chironomidae/metabolismo , Sedimentos Geológicos/química , Oligoelementos/análisis , Uranio/análisis , Uranio/farmacocinética , Contaminantes Radiactivos del Agua/análisis , Animales , Disponibilidad Biológica , Biota , Coloides/metabolismo , Francia , Minería , Agua/química , Contaminantes Químicos del Agua/análisis
6.
AAPS PharmSciTech ; 20(2): 55, 2019 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-30618013

RESUMEN

Superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively studied in biomedical applications for therapeutic or diagnostic purposes. Stability is one of the key determinants dictating successful application of these nanoparticles (NPs) in biological systems. In this study, SPIONs were synthesized and coated with two protective shells-poly(methacrylic acid) (PMAA) or citric acid (CA)-and the stability was evaluated in biologically relevant media together with effect of serum protein supplementation. The stabilities of SPION, SPION-PMAA and SPION-CA in water, DMEM, RPMI, DMEM with 10% (v v-1), and RPMI with 10% (v v-1) fetal bovine serum were determined. Without protective shells, the NPs were not stable and formed large aggregates in all media tested. CA improved the stability of the NPs in water, but was not very effective in improving stability in cell culture media. Addition of serum slightly improved colloidal stability of SPION-CA, whereas inclusion of serum significantly improved the colloidal stability of SPION-PMAA. Serum proteins also found to enhance cellular viability of MCF-7 breast cancer cells after exposure to high concentrations of SPION-PMAA and SPION-CA. Different patterns of serum proteins binding to the NPs were observed, and cellular uptake in MCF-7 cells were investigated. The stabilized SPION-PMAA and SPION-CA NPs showed uptake activity with minimal background attachment. Therefore, the importance of colloidal stability of SPIONs for utilizing in future therapeutic or diagnostic purposes is illustrated.


Asunto(s)
Proteínas Sanguíneas/metabolismo , Neoplasias de la Mama/metabolismo , Coloides/metabolismo , Nanopartículas de Magnetita , Proteínas Sanguíneas/química , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Coloides/química , Estabilidad de Medicamentos , Femenino , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Células MCF-7 , Nanopartículas de Magnetita/química , Tamaño de la Partícula , Propiedades de Superficie
8.
Acta Biomater ; 9(3): 5780-7, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23164944

RESUMEN

In this study, we demonstrate the control of protein adsorption by tailoring the sulfonate group density on the surface of colloidal alumina particles. The colloidal alumina (d(50)=179±8nm) is first accurately functionalized with sulfonate groups (SO(3)H) in densities ranging from 0 to 4.7SO(3)H nm(-2). The zeta potential, hydrophilic/hydrophobic properties, particle size, morphology, surface area and elemental composition of the functionalized particles are assessed. The adsorption of three model proteins, bovine serum albumin (BSA), lysozyme (LSZ) and trypsin (TRY), is then investigated at pH 6.9±0.3 and an ionic strength of 3mM. Solution depletion and zeta potential experiments show that BSA, LSZ and TRY adsorption is strongly affected by the SO(3)H surface density rather than by the net zeta potential of the particles. A direct correlation between the SO(3)H surface density, the intrinsic protein amino acid composition and protein adsorption is observed. Thus a continuous adjustment of the protein adsorption amount can be achieved between almost no coverage and a theoretical monolayer by varying the density of SO(3)H groups on the particle surface. These findings enable a deeper understanding of protein-particle interactions and, moreover, support the design and engineering of materials for specific biotechnology, environmental technology or nanomedicine applications.


Asunto(s)
Óxido de Aluminio/metabolismo , Coloides/metabolismo , Proteínas/metabolismo , Ácidos Sulfónicos/metabolismo , Adsorción , Animales , Bovinos , Pollos , Concentración de Iones de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Punto Isoeléctrico , Modelos Moleculares , Muramidasa/metabolismo , Albúmina Sérica Bovina/metabolismo , Electricidad Estática , Propiedades de Superficie , Sus scrofa , Tripsina/metabolismo
9.
Environ Sci Technol ; 45(1): 262-7, 2011 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-21141820

RESUMEN

A 0.01 M CaCl(2) extraction is often used to asses the bioavailability of plant nutrients in soils. However, almost no correlation was found between selenium (Se) in the soil extraction and Se content in grass. The recently developed anion Donnan membrane technique was used to analyze chemical speciation of Se in the 0.01 M CaCl(2) extractions of grassland soils and fractionation of DOC (dissolved organic carbon). The results show that most of Se (67-86%) in the extractions (15 samples) are colloidal-sized Se. Only 13-34% of extractable Se are selenate, selenite and small organic Se (<1 nm). Colloidal Se is, most likely, Se bound to or incorporated in colloidal-sized organic matter. The dominant form of small Se compounds (selenate, selenite/small organic compounds) depends on soil. A total of 47-85% of DOC is colloidal-sized and 15-53% are small organic molecules (<1 nm). In combination with soluble S (sulfur) and/or P (phosphor), concentration of small DOC can explain most of the variability of Se content in grass. The results indicate that mineralization of organic Se is the most important factor that controls Se availability in soils. Competition with sulfate and phosphate needs to be taken into account. Further research is needed to verify if concentration of small DOC is a good indicator of mineralization of soil organic matter.


Asunto(s)
Carbono/química , Selenio/química , Suelo/química , Oligoelementos/química , Carbono/metabolismo , Coloides/química , Coloides/metabolismo , Países Bajos , Fósforo/química , Fósforo/metabolismo , Poaceae/metabolismo , Selenio/metabolismo , Compuestos de Selenio/química , Compuestos de Selenio/metabolismo , Soluciones/química , Soluciones/metabolismo , Oligoelementos/metabolismo
10.
Int J Pharm ; 381(2): 205-13, 2009 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-19596430

RESUMEN

In this study, the potential of lecithin/chitosan nanoparticles (NPs) as a mucoadhesive colloidal nanosystem for transmucosal delivery of melatonin was investigated. The size, zeta potential and melatonin loading of the lecithin/chitosan NPs were investigated as a function of lecithin type (Lipoid S45, S75 and S100) and chitosan content in the preparation. The NPs were characterised by mean diameter and zeta potential ranging between 121.6 and 347.5 nm, and 7.5 and 32.7 mV, respectively, and increasing with lecithin-negative charge and chitosan content in the preparation. Melatonin loadings were up to 7.1%. All NPs were characterised by prolonged release profiles with an initial burst (approximately 25%), followed by a slow release phase. Approximately 60-70% of melatonin was released in 4h. The permeability of melatonin was investigated using Caco-2 cells as an in vitro model of the epithelial barrier. Melatonin permeability from an NP suspension prepared with Lipoid S45 lecithin and a lecithin-to-chitosan weight ratio (L/C) of 20:1 (sample C2) was significantly improved compared to the permeability of melatonin from the solution (P<0.001) and from all other NPs investigated (P<0.05). The results obtained by the cell viability studies (MTT and LDH leakage assays) showed that C2 NP suspension did not induce plasma membrane damage or decrease cell viability and could be safely applied to Caco-2 cells in the concentration range tested (<400 microg/ml).


Asunto(s)
Materiales Biocompatibles/química , Quitosano/química , Portadores de Fármacos/química , Lecitinas/química , Melatonina/química , Nanopartículas/química , Algoritmos , Materiales Biocompatibles/metabolismo , Células CACO-2 , Supervivencia Celular/efectos de los fármacos , Quitosano/metabolismo , Coloides/química , Coloides/metabolismo , Relación Dosis-Respuesta a Droga , Portadores de Fármacos/metabolismo , Estabilidad de Medicamentos , Impedancia Eléctrica , Técnicas Electroquímicas , Humanos , Mucosa Intestinal/metabolismo , Lecitinas/metabolismo , Melatonina/metabolismo , Mucinas/metabolismo , Nanopartículas/ultraestructura , Tamaño de la Partícula , Permeabilidad , Solubilidad , Suspensiones/química , Suspensiones/metabolismo
11.
Int J Pharm ; 289(1-2): 189-95, 2005 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-15652211

RESUMEN

The interference of colloidal tin oxides on the biodistribution of (99m)Technetium radiolabeled chitosan nanoparticles has been overcome by using sodium borohydride instead of commonly used stannous salts as reducing agent for the reduction of (99m)Tc (VII) to lower valency states. Biodistribution of radiolabeled chitosan nanoparticles prepared by using stannous chloride method revealed localization of the radioactivity mainly in the liver and spleen while that of radiolabeled chitosan nanoparticles prepared by using sodium borohydride method manifested the presence of radioactivity in blood up to an extent of 10% even after 2 h. Interestingly, the reduction of radioactivity in the latter case with the progress of time was not manifested through an increase in activity in the liver. Rather, a time dependent increased accumulation of radioactive materials was observed in the stomach. From the results it has been concluded that the biodistribution is strongly influenced by the presence of colloidal particles of tin oxides and (99m)Tc labeled chitosan nanoparticles are RES evading and long circulating in blood when Tc (VII) is reduced by sodium borohydride and not by stannous chloride during radiolabeling process.


Asunto(s)
Coloides/farmacología , Marcaje Isotópico/métodos , Nanoestructuras/química , Compuestos de Organotecnecio/química , Compuestos de Organotecnecio/metabolismo , Compuestos de Estaño/farmacología , Distribución Tisular , Animales , Borohidruros/sangre , Borohidruros/química , Borohidruros/farmacología , Quitosano/sangre , Quitosano/química , Quitosano/farmacología , Coloides/química , Coloides/metabolismo , Evaluación Preclínica de Medicamentos/métodos , Marcaje Isotópico/tendencias , Ratones , Ratones Endogámicos , Compuestos de Organotecnecio/farmacología , Conejos , Tecnecio , Tecnología Farmacéutica/métodos , Tecnología Farmacéutica/tendencias , Compuestos de Estaño/sangre , Compuestos de Estaño/química , Compuestos de Estaño/metabolismo
12.
Water Sci Technol ; 52(10-11): 185-92, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16459791

RESUMEN

This work presents a thorough fractionation of COD in raw sewage, followed by pilot plant coagulation tests with low-dosage lime (pH 9). Through a physical separation (sieving and crossflow filtration) total COD in the raw sewage was partitioned among eight size fractions in the range of 150-0.02 microm. In addition, respirometric tests were performed to measure the biodegradability of the different size fractions. More than 60% of COD was associated with settleable and supracolloidal particles (size > 1 microm), which are characterised by slow biodegradability. Coagulation with lime increased COD removal efficiencies in the primary treatment from typical 30-35%, up to 65-70%, suggesting that lime may induce the almost complete removal of the slowly settling, slowly biodegradable supracolloidal particles in the primary treatment. On the basis of these results a non-conventional sewage treatment scheme is proposed, considering that there is plenty of space for improving primary treatment efficiency through sewage coagulation. Higher primary treatment efficiency may present several advantages, including lower aeration energy in the subsequent biological unit and higher energy recovery from sludge digestion.


Asunto(s)
Compuestos de Calcio/farmacología , Óxidos/farmacología , Aguas del Alcantarillado/análisis , Eliminación de Residuos Líquidos/métodos , Contaminantes del Agua/aislamiento & purificación , Biodegradación Ambiental , Coloides/química , Coloides/aislamiento & purificación , Coloides/metabolismo , Filtración , Concentración de Iones de Hidrógeno , Oxígeno/química , Oxígeno/metabolismo , Tamaño de la Partícula , Aguas del Alcantarillado/química , Aguas del Alcantarillado/microbiología , Factores de Tiempo
13.
Endocrinology ; 131(2): 729-35, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1379163

RESUMEN

We have recently demonstrated that the iv administration of 0.6-60 micrograms/kg.day of acidic fibroblast growth factor (acidic FGF) increases thyroid weight in male and female rats. Interestingly, measurement of serum TSH and thyroid hormones in rats treated with 6 micrograms/kg.day acidic FGF for 30 days revealed only a slight increase in serum T4 and reverse T3 concentrations. Since thyroid function was only examined 24 h after the 30th daily treatment, we performed a series of experiments to evaluate the effects of acidic FGF on thyroid function following single and 6 multiple injections of acidic FGF. There was a small increase in the serum TSH concentrations at 2, 4, 8, and 24 h after a single high dose iv injection of acidic FGF (60 micrograms/kg). In contrast, serum T3 concentrations were slightly decreased at 2, 4, and 8 h after acidic FGF administration. There was no effect of a single injection of acidic FGF on serum T4, reverse T3, or thyroglobulin concentrations. After 6 days of treatment, there was a 34% increase in the thyroid weights of rats treated with acidic FGF. Analysis of serum hormones revealed a slight increase in serum TSH, T3, and T4 concentrations in acidic FGF-treated rats, but no change in serum reverse T3 or thyroglobulin concentrations. There was no effect of acidic FGF administration on thyroid radioiodine uptake, the intrathyroidal metabolism of radioiodine, or the relative amounts of thyroidal thyroglobulin or peroxidase messenger RNAs, or on liver 5'-deiodinase activity. In hypophysectomized rats, with no detectable levels of serum TSH, acidic FGF failed to increase thyroid weight. These data suggest that FGFs may participate with TSH in the regulation of thyroid weight and colloid accumulation, and that autocrine or paracrine growth factors may be involved in the pathogenesis of colloid goiter.


Asunto(s)
Coloides/metabolismo , Factor 1 de Crecimiento de Fibroblastos/farmacología , Bocio/etiología , Glándula Tiroides/fisiopatología , Animales , Hipofisectomía , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/metabolismo , Radioisótopos de Yodo , Hígado/enzimología , Masculino , Tamaño de los Órganos , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas , Proteínas Recombinantes/farmacología , Glándula Tiroides/patología , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA